This site is part of the Siconnects Division of Sciinov Group
This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.
ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
07-22, 2025
The global medical biosensors market is growing rapidly driven by rising chronic disease rates technological advancements, and the shift toward personalized, non-invasive healthcare. These sensors enable real-time monitoring and accurate diagnostics making them vital for point-of-care use and home-based care. Innovations in miniaturization, sensitivity, and wireless tech are expanding their applications beyond traditional settings.
Despite challenges like strict regulations and high R&D costs ongoing innovation and growing global healthcare demands are expected to drive continued growth in the medical biosensors market.
Industry Trends:Advances in nanotechnology, microelectronics and AI are making biosensors smaller more accurate and smarter—enabling real-time monitoring, remote diagnostics, and predictive healthcare. These innovations support early disease detection personalized medicine and telehealth. Notably in February 2025 the University of Oulu launched a major research project on next-gen molecular biosensors, backed by nearly €1 million in funding..
Research Methodology: The report uses a dual-source approach combining primary and secondary research to analyze regulatory trends market dynamics, technological shifts, and competitive landscapes.
Market Segmentation:
Product Type: Wearable & Non-Wearable Biosensors
Application: Diagnostics, Monitoring, Therapeutics, Others
Surge in MedTech M&A Activity:
Mergers and acquisitions in medtech are on the rise, with a strong focus on AI-driven diagnostics remote monitoring and biosensor innovations. Investment is growing in startups developing next-gen biosensors for real-time tracking and personalized care—trends expected to gain momentum through 2025.
Illumina to Acquire SomaLogic:
Illumina plans to acquire SomaLogic for up to $425 million to boost its multi-omics diagnostics capabilities. The deal enhances Illumina’s position in biosensing and personalized medicine by integrating SomaLogic’s expertise in aptamer-based proteomics.
Source:https://www.openpr.com/news/4113910/medical-biosensors-market-is-projected-to-grow-to-around-usd